Methods and compositions for positron emission tomography myocardial perfusion imaging

US9789211B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9789211-B2
Application numberUS-201314401470-A
CountryUS
Kind codeB2
Filing dateMar 15, 2013
Priority dateMay 14, 2012
Publication dateOct 17, 2017
Grant dateOct 17, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides compounds and compositions useful as imaging tracers for positron emission tomography myocardial perfusion imaging (PET MPI). Compounds in accordance with embodiments of the invention will generally comprise three structural elements: i) a triphenylphosphonium moiety; ii) a chelating element; and iii) a hydrophobic element. The tracer compounds are preferably radiolabeled with 64 Cu or 18 F. Also provided are methods for synthesizing the compounds, methods for derivatizing the compounds, and derivatives thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A multi-unit molecule useful as an imaging tracer, comprising: one or more cationic units; one or more hexaaza sacophogine cage (sar) multifunctional chelator units; and one or more hydrophobic units, wherein said one or more cationic units, one or more sar multifunctional chelator units and one or more hydrophobic units may be linked directly to each other or via a linker arranged in any sequential order in a linear linkage, wherein said one or more cationic units is selected from the group consisting of TPP, —P + R 1 R 2 R 3 and —N + R 1 R 2 R 3 , wherein R 1 , R 2 , and R 3 are each independently selected from an optionally substituted aryl, an optionally substituted aralkyl, an optionally substituted alkyl, an optionally substituted cycloalky, or an optionally substituted heteroaryl, wherein said one or more sar multifunctional chelator units is one selected from the group consisting of BaBaSar, AnAnSar, BaAnSar, BaMalSar, and MalMalSar, wherein said one or more hydrophobic units is selected from the group consisting of: 2. The multi-unit molecule of claim 1 , wherein said one or more sar multifuncitional chelator units is complexed with 64 Cu, 68 Ga, or an equivalent thereof. 3. The multi-unit molecule of claim 1 , wherein said one or more sar multifunctional chelator units is functionalized with at least one of N3, alkyne, norbornene, tetrazine, cyclooctyne and cyclooctene. 4. A method of imaging a subject's heart, comprising: administering a composition containing an effective amount of the multi-unit molecule according to claim 2 ; and taking images of the subject's heart using a suitable imagining device. 5. A method of forming a imaging tracer of claim 1 , useful as a PET tracer for myocardial perfusion imaging, comprising: linking one or more cationic units and one or more hydrophobic units to one or more hexaaza sacophogine cage (sar) multifunctional chelator units in a linear arrangement to form a multi-unit molecule, wherein said units may be linked to each other directly or via a linker in any sequential order; and labeling said multi-unit molecule with a suitable radio-active isotope selected from 64 Cu, 68 Ga, or equivalents thereof. 6. An imaging reagent kit, comprising: a composition containing a multi-unit molecule according to claim 1 , wherein said multi-unit molecule further includes a 64 Cu label; and an instruction for producing and administering an imaging tracer using said composition.

Assignees

Inventors

Classifications

  • A61K49/04Primary

    X-ray contrast preparations · CPC title

  • for diagnosis of the heart · CPC title

  • chelates from cyclic ligands, e.g. DOTA · CPC title

  • Emission tomography · CPC title

  • A61K51/044Primary

    having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins (rifampin A61K51/0459) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9789211B2 cover?
This invention provides compounds and compositions useful as imaging tracers for positron emission tomography myocardial perfusion imaging (PET MPI). Compounds in accordance with embodiments of the invention will generally comprise three structural elements: i) a triphenylphosphonium moiety; ii) a chelating element; and iii) a hydrophobic element. The tracer compounds are preferably radiolabele…
Who is the assignee on this patent?
Conti Peter S, Liu Shuanglong, Li Zibo, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61K49/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).